Shanghai plans not to invite bids for the catalogue of low-cost drugs to give "green light" to low-cost drugs

Source: great wisdom astak news agency November 28, 2013, Shanghai Pharmaceutical bidding will open up a new channel for low-cost drugs People familiar with the matter told the big smart news agency that in the next bidding, Shanghai will not invite bids for the selected low-cost drugs listed by the national development and Reform Commission, but will directly link to the Internet and be selected by the hospital itself At the beginning of November, the national development and Reform Commission began to prepare the catalogue of low-cost drugs, and internally transmitted the draft to the provincial price authorities At last week's drug price meeting of the national development and Reform Commission, the list of low-cost drugs was discussed With the development of low-cost drug catalog, whether the welfare can be reflected in the bidding has become a concern of the industry In the new round of drug bidding, Hunan, Guangdong, Shandong, Gansu and other places have formulated low-cost / cheap drug catalogs: Hunan has made clear the unified price of cheap drugs and then directly linked to the Internet; Guangdong has stipulated that only through economic and technical bids, production enterprises that meet the market price can win the bid; Shandong has also included cheap drugs in a separate procurement catalog Although the means of each province are different, they are all a kind of policy protection and preference for low-cost drugs In fact, the protection of low-cost drugs was not put on the agenda this year In the last round of bidding, due to the "only low price" bidding rules, a large number of drugs appeared because of the low price and the weak production power of pharmaceutical enterprises, which eventually led to many low-cost drugs in an emergency In 2011, Guangdong began to implement the low-cost drug catalog, and Beijing also released the corresponding low-cost drug catalog and shortage drug catalog These drugs are directly linked to the Internet, and no longer based on the price level as the basis for winning the bid Under the background that the development and Reform Commission plans to issue the catalogue of low-cost drugs, Shanghai plans not to bid for low-cost drugs The head of the industry association added that Shanghai plans to adopt the catalogue of the development and Reform Commission completely, and the plan should be formulated after the catalogue of the development and Reform Commission is issued Before that, Niu Zhengqian, vice president of China Pharmaceutical Enterprise Management Association, said that for the generic drugs that are in short supply due to the low price, market principles should be applied to regulate their supply and demand, and there is no need to purchase them as short drugs.